1 |
Al-Dubai SAR, Alshagga MA, Al-Naggar RA, et al (2010). Knowledge, attitudes and barriers for human papilloma virus (HPV) vaccines among Malaysian women. Asian Pac J Cancer Prev, 11, 887-92.
|
2 |
Brewer N, Fazekas K (2007). Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med, 45, 107-14.
DOI
|
3 |
Calloway C, Jorgensen CM, Saraiya M, et al (2006). A content analysis of news coverage of the HPV vaccine by the US newspaper. J Womens Health, 15, 803-9.
DOI
|
4 |
Cheah P (1994). Human papillomavirus related diseases in Malaysians. Malaysian J Pathol, 16, 15-7.
|
5 |
Christian WJ, Christian A, Hopenhayn C (2009). Acceptance of the HPV vaccine for adolescent girls: Analysis of the state-added questions from the BRFSS. J Adolescent Health, 44, 437-45.
DOI
|
6 |
Faridi R, Zahra A, Khan K, et al (2011). Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virol J, 8, 269.
DOI
|
7 |
Gloria YH, Studentsov Y, Bierman R, et al (2004). Natural history of human papillomavirus type 16 virus like particle antibodies in young women. cancer epidemiology, Biomarkers Prev, 13, 110-6.
DOI
|
8 |
Goncalves AK, Cobucci RN, Rodrigues HM, et al (2014). Safety, tolerability and side effects of human papillomavirus vaccines: a systemic quantitative review. Brazilian J Infectious Disease, 18, 651-9.
DOI
|
9 |
Jain N, Euler GL, Shefer A, et al (2009). Human papillomavirus (HPV) awareness and vaccination among women in the united states, national immunization Survey-Adult 2007. Prev Med, 48, 426-31.
DOI
|
10 |
Lim BK, Ng KY, Omar J, et al (2014). Immunogenicity and Safety of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine in malaysian women aged 18-35 years: a randomized controlled Trial. Med J Malaysia, 69, 1-8.
|
11 |
Othman N, Rebolj M (2009). Challenges to cervical cancer screening in a developing country: the case of Malaysia. Asian Pac J Cancer Prev, 10, 747-52.
|
12 |
Rambout L, Tashkandi M, Hopkins L, et al (2014). Self-reported barriers and facillitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systemic review. Prev Med, 58, 22-32.
DOI
|
13 |
Sam I-C, Path MRC, Wong LP, et al (2009). Maternal acceptance of human papillomavirus vaccine in Malaysia. J Adolescent Health, 44, 610-2.
DOI
|
14 |
Schiffman M, Castle P, Jeronimo J, et al (2007). Human papillomavirus and cervical cancer. Lancet, 370, 890-907.
DOI
|
15 |
Sherris J, Friedman A, Wittet S, et al (2006). Chapter 25: Education, training and communication for HPV vaccines. Vaccines, 24, 210-8.
DOI
|
16 |
Wong LP (2008). Young Multiethnic women’s attitute toward the HPV vaccine and HPV vaccination. Int J Gynaecol Obstetrics, 103, 131-5.
DOI
|
17 |
Wong LP (2009). Preventing cervical cancer through human papillomavirus vaccination : prespective from focus group. JLower Genital Tract Disease, 13, 85-93.
DOI
|
18 |
Wong LP (2010). Knowledge and Attitude about HPV infection, HPV vaccination and cervical cancer among rural southeast Asian women. Int Soc Behavioural Med, 18, 105-11.
|